Your browser doesn't support javascript.
loading
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors.
Hong, David S; LoRusso, Patricia; Hamid, Omid; Janku, Filip; Kittaneh, Muaiad; Catenacci, Daniel V T; Chan, Emily; Bekaii-Saab, Tanios; Gadgeel, Shirish M; Loberg, Robert D; Amore, Benny M; Hwang, Yuying C; Tang, Rui; Ngarmchamnanrith, Gataree; Kwak, Eunice L.
Afiliação
  • Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org.
  • LoRusso P; Medical Oncology, Yale Cancer Center, New Haven, Connecticut.
  • Hamid O; Melanoma Center, The Angeles Clinic and Research Institute, Los Angeles, California.
  • Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kittaneh M; Hematology/Oncology, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.
  • Catenacci DVT; Hematology/Oncology, University of Chicago, Chicago, Illinois.
  • Chan E; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Bekaii-Saab T; Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona.
  • Gadgeel SM; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Loberg RD; Thoracic Oncology, Karmanos Cancer Institute, Detroit, Michigan.
  • Amore BM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.
  • Hwang YC; Oncology Biomarkers, Amgen Inc., Thousand Oaks, California.
  • Tang R; Clinical Pharmacology, Modeling and Simulation, Amgen Inc., South San Francisco, California.
  • Ngarmchamnanrith G; Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, California.
  • Kwak EL; Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, California.
Clin Cancer Res ; 25(8): 2403-2413, 2019 Apr 15.
Article em En | MEDLINE | ID: mdl-30425090

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article